Latest News
FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma
25 September 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Friday that the US Food and Drug Administration (FDA) has approved WELI...
AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer
25 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Friday that the US Food and Drug Administration (FDA) has accepted and granted Priority Review to its supplemental Biologics License Application...
Novotech to acquire Agilex Biolabs from Healius
25 September 2026 - Novotech, a clinical research organisation (CRO) and scientific advisory company, announced on Friday that it has agreed to acquire Agilex Biolabs, a specialist bioanalytical laboratory business headquartered in Adelaide, Australi...
ACROBiosystems launches CHO-Direct and ACRO AIx to accelerate AI-driven drug discovery
25 September 2026 - US biotechnology company ACROBiosystems on Thursday unveiled its latest innovation portfolio, featuring ACRO AIx, CHO-Direct and GlobalLifeShip cross border supply chain to respond the demands of the AI-driven drug discovery era.C...
UChicago Medicine completes construction phase of new cancer facility
25 September 2026 - The University of Chicago Medicine announced on Thursday the completion of the construction phase of the AbbVie Foundation Cancer Pavilion.Scheduled to open in April 2027 on UChicago Medicine's main campus in Hyde Park on the...